Dual-binding nanoparticles improve the killing effect of T cells on solid tumor

Adoptive cell therapy (ACT) was one of the most promising anti-tumor modalities that has been confirmed to be especially effective in treating hematological malignancies. However, the clinical efficacy of ACT on solid tumor was greatly hindered by the insufficient tumor-infiltration of cytotoxic CD8...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Zhenyu, Luo, Lihua, Lu, Yichao, Zhu, Chunqi, Qin, Bing, Jiang, Mengshi, Li, Xiang, Shi, Yingying, Zhang, Junlei, Liu, Yu, Shan, Xinyu, Yin, Hang, Guan, Guannan, Du, Yongzhong, Cheng, Ningtao, You, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171930/
https://www.ncbi.nlm.nih.gov/pubmed/35672752
http://dx.doi.org/10.1186/s12951-022-01480-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171930/
https://www.ncbi.nlm.nih.gov/pubmed/35672752
http://dx.doi.org/10.1186/s12951-022-01480-z

Ejemplares similares